UnitedHealth CEO Hemsley acquires 50 dividend shares
The award was a dividend equivalent on vested deferred stock units and immediately vested under the units' terms.
Rhea-AI Filing Summary
UnitedHealth Group Inc. CEO, UHG and director Stephen J. Hemsley acquired 50 common shares on September 22, 2026, as dividend equivalents paid on vested deferred stock units. The equivalents were immediately vested and subject to the same terms as the underlying units. Direct holdings after the transaction were 177,690 shares, including 129,541 shares transferred from trusts on August 27, 2026. Reported indirect holdings were 359 shares by a 401(k) and 877,290 shares by trusts. No Rule 10b5-1 plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1, F2 | 50 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock F3 | -- | -- | -- |
Footnotes (3)
- F1. Represents dividend equivalents paid on vested deferred stock units. The dividend equivalents are immediately vested and are subject to the same terms as the underlying deferred stock units.
- F2. Includes 129,541 shares previously owned indirectly by trusts which were transferred to the reporting person's direct holdings on August 27, 2026. This transaction was exempt from reporting pursuant to Rule 16a-13.
- F3. Excludes 129,541 shares previously owned indirectly by trusts which were transferred to the reporting person's direct holdings on August 27, 2026. This transaction was exempt from reporting pursuant to Rule 16a-13.
Key Figures
Key Terms
dividend equivalents financial
deferred stock units financial
Rule 16a-13 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What were Stephen J. Hemsley's UNH stock holdings after the transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.